Zydus Cadila gets USFDA nod to market mineral supplement

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Potassium Chloride extended release tablets in the strengths of 10 mEq (750 mg) and 20 mEq (1,500 mg), Zydus Cadila, part of Cadila Healthcare group, said in a BSE filing.

from Moneycontrol Business News https://ift.tt/3muw5iR